Paul R. Lichter, M.D.
Publications

Jampol LM, Packer S, Mills RP, Day SH, Lichter PR. A perspective on commercial relationships between ophthalmology and industry. Arch Ophthalmol 2009;127:1194-1202.

Parrish RK, 2nd, Feuer WJ, Schiffman JC, Lichter PR, Musch DC. Five-year follow-up optic disc findings of the Collaborative Initial Glaucoma Treatment Study. Am J Ophthalmol 2009;147:717-724.e1. Epub 2009 Jan 18.

Lichter PR. Continuing medical education, physicians, and Pavlov: can we change what happens when industry rings the bell? Arch Ophthalmol 2008;126:1593-1597.

Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK. Visual field progression in the Collaborative Initial Glaucoma Treatment Study: The impact of treatment and other baseline factors. Ophthalmology 2009;116:200-207. Epub 2008 Nov 18.

Lichter PR. Debunking Myths in Physician-Industry Conflicts of Interest. Am J Ophthalmol 2008;146:159-171. Epub 2008 Jun 6.

Lichter PR, Musch DC, Janz NK. The Investigators' Perspective on the Collaborative Initial Glaucoma Treatment Study (CIGTS). Arch Ophthalmol 2008;126:122-124.

Musch DC, Gillespie BW, Niziol LM, Cashwell LF, Lichter PR. Factors associated with intraocular pressure before and during 9 years of treatment in the collaborative initial glaucoma treatment study. Ophthalmology 2008 Jun;115:927-933. Epub 2007 Oct 26.

Jampel HD, Frick KD, Janz NK, Wren PA, Musch DC, Rimal R, Lichter PR. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol 2007;144:238-244. Epub 2007 Jun 11.

Janz NK, Wren PA, Guire KE, Musch DC, Gillespie BW, Lichter PR. Fear of blindness in the Collaborative Initial Glaucoma Treatment Study patterns and correlates over time. Ophthalmology 2007;114:2213-2220. Epub 2007 May 8.

Hewitt AW, Samples JR, Allingham RR, Jarvela I, Kitsos G, Krishnadas SR, Richards JE, Lichter PR, Petersen MB, Sundaresan P, Wiggs JL, Mackey DA, Wirtz MK. Investigation of founder effects for the Thr377Met Myocilin mutation in glaucoma families from differing ethnic backgrounds. Mol Vis 2007;13:487-492.

Ayala-Lugo RM, Pawar H, Reed DM, Lichter PR, Moroi SE, Page M, Eadie J, Azocar V, Maul E, Ntim-Amponsah C, Bromley W, Obeng-Nyarkoh E, Johnson AT, Kijek TG, Downs CA, Johnson JM, Perez-Grossmann RA, Guevara-Fujita ML, Fujita R, Wallace MR, Richards JE. Variation in optineurin (OPTN) allele frequencies between and within populations. Mol Vis 2007;13:151-163.

Musch DC, Gillespie BW, Niziol LM, Janz NK, Wren PA, Rockwood EJ, Lichter PR; Collaborative Initial Glaucoma Treatment Study Group. Collaborative Initial Glaucoma Treatment Study Group. Cataract extraction in the collaborative initial glaucoma treatment study: incidence, risk factors, and the effect of cataract progression and extraction on clinical and quality-of-life outcomes. Arch Ophthalmol 2006;124:1694-1700.

Hudson HL, Lane SS, Heier JS, Stulting RD, Singerman L, Lichter PR, Sternberg P, Chang DF; IMT-002 Study Group. IMT-002 Study Group. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology 2006;113:1987-2001.

Woodroffe A, Krafchak CM, Fuse N, et al. Ordered subset analysis supports a glaucoma locus at GLC1I on chromosome 15 in families with earlier adult age at diagnosis. Exp Eye Res 2006;82:1068-1074.

Krafchak CM, Pawar H, Moroi SE, et al. Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am J Hum Genet 2005;77:694-708.

Musch DC, Gillespie BW, Motyka BM, et al. Converting to SITA-standard from full-threshold visual field testing in the follow-up phase of a clinical trial. Invest Ophthalmol Vis Sci 2005;46:2755-2759.

Jampel HD, Musch DC, Gillespie BW, et al.; Collaborative Initial Glaucoma Treatment Study Group. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 2005;140:16-22.

Zareparsi S, Buraczynska M, Branham KE, et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005;14:1449-1455.

Eibschitz-Tsimhoni M, Lichter PR, DelMonte MA, Archer SM, Musch DC, Schertzer RM, Moroi SE. Assessing the need for posterior sclerotomy at the time of filtering surgery in patients with Sturge-Weber syndrome. Ophthalmology 2003;110:1361-1363.

Lichter, PR. Glaucoma clinical trials and what they mean for our patients [Perspective]. Am J Ophthalmol 2003;136:136-145.

Gillespie BW, Musch DC, Guire KE, Mills RP, Lichter PR, Janz NK, Wren PA. The Collaborative Initial Glaucoma Treatment Study (CIGTS): baseline visual field and test-retest variability. IOVS 2003;44:2613-2620.

Lim P, Lichter PR, Higashi M, Downs CA, Richards JE. Septuagenarian's phenotype leads to ascertainment of familial MYOC gene mutation. J Glaucoma 2003;12:98-103.

Lichter PR. Impact of intraocular pressure reduction on glaucoma progression [commentary]. JAMA 2002;288:2607-2608.

Lichter PR. Expectations from clinical trials. Arch Ophthalmol 2002;120:1371-1372.

Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study Interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology 2001;108:1954-1965.

Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in The Collaborative Initial Glaucoma Treatment Study Comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943-1953.

The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am J Ophthalmol 2001;132:311-320.

The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 8. Risk of cataract formation after trabeculectomy. Arch Ophthalmol 2001;119:1771-1780.

Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study Quality of life in newly diagnosed glaucoma patients. Ophthalmology 2001;108:887-898.

The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-440.

The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 16. Effect of cataract on visual field and visual acuity. Arch Ophthalmol 2000;118:1639-1652.

Shimizu S, Lichter PR, Johnson AT, et al. Age-dependent prevalence of mutations at the GLC1A locus in primary open angle glaucoma. Am J Ophthalmol 2000;130:165-177.

Musch DC, Lichter PR, Guire KE, et al. The Collaborative Initial Glaucoma Treatment Study - Study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 1999;106:653-662.